BrainStorm Cell Therapeutics; I Anticipate A Positive AdCom But There Are Major Risks
koto_fejaOverview of the thesis Brainstorm Cell Therapeutics (NASDAQ:BCLI) is developing cellular therapies for neurodegenerative diseases. BCLI has completed a phase ...